Form 4 for XENE Xenon Pharmaceuticals Inc.
Accepted 2021-12-10 00:00:00 ET · period of report 2021-12-08 · accession 0001209191-21-069018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-10 | 2021-12-08 | XENE | PATOU GARY | Dir | M - OptEx | $3.67 | +2,057 | 25.6K | +9% | +$7,549 |
| D | 2021-12-10 | 2021-12-08 | XENE | PATOU GARY | Dir | M - OptEx | $0.00 | -2,057 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2021-12-08 | M | A | 2,057 | $3.67 | 25,630 | D | — | — | (F1) The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-12-08 | M | D | 2,057 | $0.00 | 0 | D | $3.67 · — to 2021-12-31 | 2,057 Common Shares | (F1) The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. (F3) 1/3 of the shares subject to the Option vested on January 1, 2013 (the "2012 Vesting Commencement Date") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the 2012 Vesting Commencement Date over the following 2 years. |